To further assess this, we determined the impact of induced mutant EGFR or KRAS on the expression of the main neuroendocrine transcription factors (NETFs) - including INSM1, BRN2, ASCL1, and NEUROD1 – in the SCLC cell lines. The gene discussed is KRAS; the disease is small cell lung carcinoma.